FENC · Fennec Pharmaceuticals Inc
United States · RS rating 83 · As of 2026-11-03
| Price | 10.70 USD |
|---|---|
| 1-day change | +1.5% |
| RS rating (overall / 1M / 3M / 12M) | 83 / 60 / 70 / 75 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 50 / 45 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +105.9% |
| Sales growth Q/Q | +10.6% |
| Distance from 52-week high | +16.3% |
| Market cap (USD) | $229.6M |